TLR2 and Parkinson disease: Another study has confirmed this result using the transgenic mice model of PD and confirmed that TLR2 activation leads to α-synuclein accumulation in neurons by inhibiting autophagy activity through the phosphatidylinositol-3-kinase mammalian target of rapamycin (AKT/mTOR) pathway [90].